Results 31 to 40 of about 928 (118)
Vitreous Mediators in Retinal Hypoxic Diseases
Mediators of Inflammation, Volume 2013, Issue 1, 2013., 2013 The causes of retinal hypoxia are many and varied. Under hypoxic conditions, a variety of soluble factors are secreted into the vitreous cavity including growth factors, cytokines, and chemokines. Cytokines, which usually serve as signals between neighboring cells, are involved in essentially every important biological process, including cell ...
Roberto dell′Omo +6 more
wiley +1 more source
Ophthalmic Research, 2009 The rate of retinal detachment in fellow control eyes of rabbits following fibroblast administration is progressively lower with increased dose of 5-Fluorouracil in the test eyes. Thus, it seems mandatory to choose control eyes in other animals rather than the fellow eyes of the treated ones.
openaire +2 more sources
Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management
Advanced Healthcare Materials, Volume 13, Issue 17, July 5, 2024.Ocular fundus neovascularization diseases are prominent etiologies of visual impairment. Specifically, nanomedicine arose at an opportune time, which has paved the way to fulfill the effective ocular fundus drug delivery and achieve precise drug release control capacity, thus further improving the therapeutic effect.
Yifan Zhou +8 more
wiley +1 more source
Journal of Ophthalmology, Volume 2024, Issue 1, 2024.Objectives. To assess the incidence and characteristics of treatment‐requiring diabetic macular edema (TR‐DME) in eyes after delayed sequential bilateral cataract surgery in patients with diabetes mellitus. Methods. This was a retrospective study involving patients with diabetes who underwent cataract surgery at Shaanxi Eye Hospital between January ...
Yuecong Ren, Hong Yan, Miguel Teus
wiley +1 more source
Retrospective Study of Diabetic Retinopathy and Macular Edema in Southern Part of Bangladesh
Journal of Ophthalmology, Volume 2024, Issue 1, 2024.Background. Diabetic mellitus is a vision‐threatening disease because it causes diabetic retinopathy worldwide. The main focus of this research is to determine the prevalence and assess the visual outcome in diabetic retinopathy and macular edema patients by injecting Bevacizumab clinically. Methods.
Md. Asif Hasan +3 more
wiley +1 more source
Towards a Device Agnostic AI for Diabetic Retinopathy Screening: An External Validation Study
Clinical Ophthalmology, 2022 Divya Parthasarathy Rao,1 Manavi D Sindal,2 Sabyasachi Sengupta,3 Prabu Baskaran,4 Rengaraj Venkatesh,2 Anand Sivaraman,5 Florian M Savoy6 1Artificial Intelligence R&D, Remidio Innovative Solutions Inc, Glen Allen, VA, USA; 2Vitreoretinal Services ...
Rao DP +6 more
doaj
Indication For Vitrectomy in A Tertiary Care Hospital
National Journal of Community Medicine, 2016 Introduction: On the basis of development in vitrectomy procedure a whole new subspecialty termed vitreoretinal surgery has evolved over past 30 years. We conducted this study to evaluate usefulness and necessity of Pars plana vitrectomy in today’s time.
Dhawal Agrawal +3 more
doaj
Personalized Management of Patients with Proliferative Diabetic Vitreoretinopathy
LifePurpose: To evaluate prognostic factors for visual outcome in patients with diabetes who have undergone vitrectomy (PPV) for severe proliferative diabetic vitreoretinopathy (PDVR) in at least one eye in the past 15 years. Methods: Medical records of 132 eyes of 66 patients were analyzed (median age 52 years 21–80; patients with type 1/2 diabetes 40/26;
Monika Ecsedy +4 more
openaire +3 more sources
Clinical Ophthalmology, 2011 Stefano Zenoni1, Mario R Romano2, Sonia Palmieri1, Natalia Comi1, Edoardo Fiorentini1, Piero Fontana11Ospedali Riuniti di Bergamo, Bergamo, Italy; 2Istituto Clinico Humanitas IRCSS, Rozzano, Milan, ItalyObjective: The aim of the study was to evaluate the
Zenoni S +5 more
doaj
Management of severe proliferative vitreo-retinopathy with perfluorocarbon liquids and silicone oil.
The Kaohsiung journal of medical sciences, 2000 12 patients of retinal detachment with advanced proliferative vitreoretinopathy were managed with intraoperative perfluoro-N-octane and postoperative silicone oil injection from March 1994 to June 1996 in Kaohsiung Medical University Hospital. The combined intraoprative procedures included posterior vitrectomy (12 eyes), membrane peeling (12 eyes ...
W C, Wu, S L, Kuo, J Y, Chen
openaire +1 more source